Product Overview: Suhagra Force 50 Cipla
Suhagra Force 50 Cipla is a pharmaceutical preparation manufactured by Cipla containing sildenafil citrate for research applications. This compound is specifically designed for laboratory investigations examining phosphodiesterase type 5 (PDE5) enzyme inhibition mechanisms and their effects on cyclic nucleotide pathways. Researchers at Stroid UK Shop utilise this preparation to study vascular smooth muscle function and nitric oxide signalling cascades in controlled laboratory environments. The formulation provides researchers with a standardised preparation for examining PDE5 inhibitor pharmacology and related biochemical processes.
Laboratory Research Applications
Scientists investigate Suhagra Force 50 in studies examining PDE5 enzyme kinetics and inhibition mechanisms in vascular tissue models. Research applications include analysing cyclic guanosine monophosphate (cGMP) degradation pathways and nitric oxide-dependent signalling cascades. Laboratories utilise this compound to study smooth muscle relaxation mechanisms and endothelial function in various experimental models. The preparation enables researchers to examine dose-response relationships and pharmacokinetic properties of sildenafil citrate in controlled settings. Studies often focus on vascular biology research and cardiovascular pharmacology investigations. Researchers examining erection drugs sildenafil citrate preparations find this compound valuable for comparative analyses. Additional research applications include investigating drug metabolism pathways and interaction studies with other pharmaceutical compounds. Laboratories also employ this preparation in studies examining phosphodiesterase selectivity and tissue-specific enzyme expression patterns. Advanced research includes examination of nitric oxide synthase pathway modulation and endothelial dysfunction models. Researchers studying various pharmaceutical categories including SARMs and peptides may utilise this compound for comparative pharmacological studies.
Technical Specifications
| Active Ingredient | Sildenafil Citrate |
|---|---|
| Manufacturer | Cipla |
| Form | Tablet |
| Strength | 50mg |
| CAS Number | 171599-83-0 (Sildenafil Citrate) |
| Molecular Formula | C₂₂H₃₀N₆O₄S·C₆H₈O₇ |
| Storage Requirements | Room temperature, dry conditions |
Research Compliance Statement
This preparation is intended exclusively for in-vitro laboratory research purposes. Suhagra Force 50 Cipla is not approved for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure proper institutional oversight and safety protocols when handling this compound. All investigations should comply with relevant laboratory safety guidelines and institutional review board requirements for pharmaceutical research.
